Nerandomilast is both effective and well-tolerated, representing a "major step forward for the treatment of progressive pulmonary fibrosis (PPF)," with its effect on clinical outcomes sustained over ...
Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting demonstrating that stereotactic body ...
1d
At 10 years, stereotactic body radiation therapy comparable to surgery for early-stage lung cancer
Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for ...
In her columns debut, Debbie Klein shares the story of her late husband Steve's idiopathic pulmonary fibrosis diagnosis.
In a clinical practice guideline published online Sept. 16 in Practical Radiation Oncology, recommendations are presented for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback